(DL)-1-HYDROXY-3,7,7,9,9-PENTAMETHYL-1,4,8-TRIAZASPIRO[4,5]DECANE-2-ONE AND METHOD FOR ITS PREPARING

FIELD: organic chemistry, chemical technology, medicine. ^ SUBSTANCE: invention relates to (DL)-1-hydroxy-3,7,7,9,9-pentamethyl-1,4,8-triazaspiro[4,5]decane-2-one of the formula (1) . ^ Also, invention describes a method for preparing this compound by treatment of DL-alanine hydroxamic acid with ket...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KONOVALOVA N.P, VYSTOROP I.V, FEDOROV B.S, VOLKOVA L.M
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:FIELD: organic chemistry, chemical technology, medicine. ^ SUBSTANCE: invention relates to (DL)-1-hydroxy-3,7,7,9,9-pentamethyl-1,4,8-triazaspiro[4,5]decane-2-one of the formula (1) . ^ Also, invention describes a method for preparing this compound by treatment of DL-alanine hydroxamic acid with ketone wherein aminoketone - 2,2,6,6-tetramethylpiperidine-4-one is used as ketone, and process is carried out in benzene medium in the mole ratio of reagents: alpha-aminohydroxamic acid : aminoketone = 1:1.1 followed by isolation of the end product. Invention provides preparing new compound that can be used as a nontoxic antimetastatic medicinal agent. ^ EFFECT: improved preparing method, valuable medicinal properties of compound. ^ 3 cl, 1 ex